Peptides DB
Research-centric peptide and protocol reference hub
Study 19 of 22PT-141 (Bremelanotide) literatureBioactive materials · Review2026

Smart-responsive electrospun scaffolds (SRES) for neural repair: Recent advances and future prospects.

Smart-responsive electrospun scaffolds represent a promising avenue for neural repair, but further research is needed to translate these findings into clinical practice.

Read at Bioactive materialsAdd to compare

Where it sits

this study against the rest of the pt-141 (bremelanotide) corpus
7
Preclinical
6
Observational
0
Open-label
2
Randomised
7
Reviews · this one

Summary and findings

The paper reviews smart-responsive electrospun scaffolds (SRES) for neural repair, focusing on their application in traumatic brain injury, spinal cord injury, and peripheral nerve injury. It highlights the scaffolds' ability to sense pathological signals and modulate repair conditions. The review integrates recent advancements and identifies future research directions.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as Bioactive materials supplied them

Neurological injuries trigger complex, multi-stage pathological cascades, while traditional clinical interventions such as drug therapy and surgical decompression can only alleviate symptoms rather than reconstruct damaged neural circuits. Conventional repair approaches face multiple limitations, including the inherently weak regenerative ability of central nervous neurons, glial scar formation post-injury, shortage of autologous nerve grafts, donor site secondary trauma and tissue size mismatch, which urgently demand novel regenerative therapeutic strategies. Tissue-engineered artificial nerve implants have opened new avenues for neural repair, among which smart-responsive electrospun scaffolds (SRES) stand out for their unique biomimetic advantage of actively sensing pathological microenvironment signals and dynamically modulating local repair conditions, greatly expanding the development of neural regenerative medicine. Benefiting from electrospinning technology, SRES have been developed targeting traumatic brain injury (TBI), spinal cord injury (SCI) and peripheral nerve injury (PNI), which realize spatiotemporally controllable drug release, biomimetic extracellular matrix construction and in-situ neuromodulation. However, a comprehensive and systematic review that integrates these scattered advancements to provide guidance for researchers remains absent. This review firstly elaborates the pathological characteristics of three typical neural injuries (TBI, SCI, PNI) and the endogenous self-repair defects of neural tissues. Afterwards, it systematically summarizes the classification of electrospinning technologies, fabrication methodologies, responsive mechanisms, and classifications of SRES, further focuses on their recent application progress in neural regeneration via bibliometric big data analysis over the past decade, critically analyzes current limitations and prospective research trends, and underscores the necessity of developing tailored electrospun smart-responsive materials, thereby offering an authoritative reference for advancing neural regeneration engineering and regenerative medicine.

Background

Neurological injuries such as traumatic brain injury, spinal cord injury, and peripheral nerve injury present significant challenges due to the limited regenerative capacity of central nervous neurons and the formation of glial scars. Traditional interventions often fail to reconstruct damaged neural circuits, necessitating innovative approaches. Smart-responsive electrospun scaffolds (SRES) have emerged as a promising strategy due to their ability to dynamically interact with the pathological microenvironment and enhance neural repair.

Methods

This paper is a review article that compiles and analyzes existing literature on smart-responsive electrospun scaffolds (SRES) for neural repair. It includes a bibliometric analysis of research progress over the past decade. The review categorizes electrospinning technologies, fabrication methodologies, and the responsive mechanisms of SRES, focusing on their application in neural regeneration.

Results

Not reported in abstract.

Interpretation

The review highlights the potential of SRES in advancing neural regeneration by offering a biomimetic approach to repair. While the scaffolds show promise in preclinical settings, the review underscores the need for further research to address current limitations and to develop tailored materials for specific neural injuries. The absence of new experimental data limits the ability to assess clinical applicability directly.

Key findings

  • SRES enable spatiotemporally controllable drug release.
  • SRES facilitate biomimetic extracellular matrix construction.
  • SRES support in-situ neuromodulation.
  • The review includes a bibliometric analysis over the past decade.

Limitations

  • No new experimental data presented.
  • Focuses on existing literature rather than original research.
  • Lacks clinical trial results.
  • Primarily preclinical focus.

Elsewhere in the PT-141 (Bremelanotide) corpus

DMultifunctional material platforms for neural interfaces: active orchestration of dynamic foreign body response across implantation lifetimes.Bioactive materials · 2026reviewBAn interpretable machine learning model for predicting febrile seizures following enterovirus infection in children.Annals of medicine · 2026 · n=446 · XGBoost model training set AUC was 0.972 (95% CI: 0.958-0.987).HumanDReal-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.Bioactive materials · 2026reviewAHMB supplementation combined with high-intensity functional exercise supports aerobic capacity but not strength in trained and untrained males: a randomized controlled trial.Journal of the International Society of Sports Nutrition · 2026 · n=90 · VO2MAX increased with HMB in TR, p=0.024.HumanDEmerging bioactive microneedle platforms for disease management: From cutaneous disorders to systemic therapeutics.Bioactive materials · 2026reviewBAnalysis of vaccine adverse events associated with rheumatoid arthritis: A pharmacovigilance study based on the VAERS database.Human vaccines & immunotherapeutics · 2026 · n=11532185 · 34,498 RA-related adverse events (0.03%) among 11,532,185 reports.Human